|
POT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.919400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.000900E-04 |
| Normal-vs-Stage2 |
6.083700E-02 |
| Normal-vs-Stage3 |
6.415000E-01 |
| Normal-vs-Stage4 |
9.318600E-01 |
| Stage1-vs-Stage2 |
9.070600E-01 |
| Stage1-vs-Stage3 |
1.665630E-02 |
| Stage1-vs-Stage4 |
1.675960E-02 |
| Stage2-vs-Stage3 |
1.320580E-01 |
| Stage2-vs-Stage4 |
1.002600E-01 |
| Stage3-vs-Stage4 |
7.787200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.200980E-03 |
| Normal-vs-AfricanAmerican |
1.087390E-01 |
| Normal-vs-Asian |
2.244600E-01 |
| Caucasian-vs-AfricanAmerican |
1.350770E-04 |
| Caucasian-vs-Asian |
4.769600E-01 |
| AfricanAmerican-vs-Asian |
1.244420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.020600E-03 |
| Normal-vs-Female |
9.642200E-02 |
| Male-vs-Female |
4.328400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.130800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.605500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.216500E-03 |
| Normal-vs-Age(81-100Yrs) |
8.879800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.379000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.986600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.985000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.843600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.516000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.264400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.248170E-01 |
| Normal-vs-Grade 2 |
8.0315000000053E-05 |
| Normal-vs-Grade 3 |
1.487850E-01 |
| Normal-vs-Grade 4 |
4.269800E-01 |
| Grade 1-vs-Grade 2 |
8.647200E-01 |
| Grade 1-vs-Grade 3 |
4.257000E-01 |
| Grade 1-vs-Grade 4 |
7.064300E-02 |
| Grade 2-vs-Grade 3 |
1.096460E-02 |
| Grade 2-vs-Grade 4 |
1.375410E-03 |
| Grade 3-vs-Grade 4 |
1.132030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.95599999927876E-08 |
| Normal-vs-ccB subtype |
5.096200E-01 |
| ccA subtype-vs-ccB subtype |
5.83479999999303E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.023600E-03 |
| Normal-vs-N1 |
7.973400E-01 |
| N0-vs-N1 |
2.148200E-01 |
|
|
